[1] Pierson TC, Lazear HM, Diamond MS. Flaviviruses. In: Howley PM, Knipe DM, editors. Fields Virology, volume 1. Lippincott Williams & Wilkins Press. 2021; 866-8.
[2] Solomon T. Control of Japanese encephalitis--within our grasp? N Engl J Med, 2006; 355, 869-71.
[3] Wang HY, Liang GD. Epidemiology of Japanese encephalitis: past, present, and future prospects. Ther Clin Risk Manage, 2015; 11, 435−48.
[4] Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ, 2011; 89, 766−74. doi:  10.2471/BLT.10.085233
[5] Griffiths MJ, Turtle L, Solomon T. Japanese encephalitis virus infection. Handb Clin Neurol, 2014; 123, 561−76.
[6] Halstead SB, Hills SL, Marfin AA, et al. Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, Offit PA. Vaccine. Elsevier. 2023, 577-600.
[7] Roy U. Structural and molecular analyses of functional epitopes and escape mutants in Japanese encephalitis virus envelope protein domain III. Immunol Res, 2020; 68, 81−9. doi:  10.1007/s12026-020-09130-y
[8] Liu H, Zhang J, Niu YZ, et al. The 5' and 3' untranslated regions of the Japanese Encephalitis Virus (JEV): molecular genetics and higher order structures. Front Microbiol, 2021; 12, 730045. doi:  10.3389/fmicb.2021.730045
[9] Uchil PD, Satchidanandam V. Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent. Am J Trop Med Hyg, 2001; 65, 242−51. doi:  10.4269/ajtmh.2001.65.242
[10] Mohammed MAF, Galbraith SE, Radford AD, et al. Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missing fifth genotype. Infect Genet Evol, 2011; 11, 855−62. doi:  10.1016/j.meegid.2011.01.020
[11] Liang GD, Li XL, Gao XY, et al. Arboviruses and their related infections in China: a comprehensive field and laboratory investigation over the last 3 decades. Rev Med Virol, 2018; 28, e1959. doi:  10.1002/rmv.1959
[12] Zhang WJ, Xu CX, Nie K, et al. Genotype 5 Japanese encephalitis virus—old genotype, new threat. Zoonoses, 2022; 2, 23.
[13] Hu YL, Lee PI. Safety of Japanese encephalitis vaccines. Hum Vaccin Immunother, 2021; 17, 4259−64. doi:  10.1080/21645515.2021.1969852
[14] Japanese Encephalitis Vaccines: WHO position paper – February 2015. Wkly Epidemiol Rec, 2015; 90, 69-87. (查阅网上资料, 未找到作者信息, 请确认补充)
[15] Fan YC, Chen JM, Chiu HC, et al. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine. PLoS Negl Trop Dis, 2012; 6, e1834. doi:  10.1371/journal.pntd.0001834
[16] Cao L, Fu SH, Gao XY, et al. Low protective efficacy of the current Japanese encephalitis vaccine against the emerging genotype 5 Japanese encephalitis virus. PLoS Negl Trop Dis, 2016; 10, e0004686. doi:  10.1371/journal.pntd.0004686
[17] Tajima S, Yagasaki K, Kotaki A, et al. In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain. J Gen Virol, 2015; 96, 2661−9. doi:  10.1099/vir.0.000213
[18] Woo JH, Jeong YE, Jo JE, et al. Genetic characterization of Japanese encephalitis virus genotype 5 isolated from patient, South Korea, 2015. Emerg Infect Dis, 2020; 26, 1002−6. doi:  10.3201/eid2605.190977
[19] Li MH, Fu SH, Chen WX, et al. Genotype V Japanese encephalitis virus is emerging. PLoS Negl Trop Dis, 2011; 5, e1231. doi:  10.1371/journal.pntd.0001231
[20] World Health Organization. Manual for the laboratory diagnosis of Japanese encephalitis virus infection. 2007; 1-52. https://cdn.who.int/media/docs/default-source/immunization/vpd_surveillance/lab_networks/manual-lab-diagnosis-je.pdf?sfvrsn=e2b62a35_4. [2023-10-19].
[21] Ye XF, Wang HY, Fu SH, et al. Etiological spectrum of clinically diagnosed Japanese encephalitis cases reported in Guizhou Province, China, in 2006. J Clin Microbiol, 2010; 48, 1343−9. doi:  10.1128/JCM.01009-09
[22] Calisher CH, Karabatsos N, Dalrymple JM, et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol, 1989; 70, 37−43. doi:  10.1099/0022-1317-70-1-37
[23] Maeki T, Tajima S, Kyaw AK, et al. Comparison of neutralizing antibody titers against Japanese encephalitis virus genotype V strain with those against genotype I and III strains in the sera of Japanese encephalitis patients in Japan in 2016. Jpn J Infect Dis, 2018; 71, 360−4. doi:  10.7883/yoken.JJID.2018.126
[24] Nguyen TTT, Tajima S, Ikeda M, et al. Neutralization potency of sera from Vietnamese patients with Japanese encephalitis (JE) against genotypes I and V JE viruses. Jpn J Infect Dis, 2019; 72, 115−7. doi:  10.7883/yoken.JJID.2018.232
[25] Shao N, Li F, Nie K, et al. TaqMan real-time RT-PCR assay for detecting and differentiating Japanese encephalitis virus. Biomed Environ Sci, 2018; 31, 208−14.
[26] Chen XJ, Wang HY, Li XL, et al. Japanese encephalitis in China in the period of 1950-2018: from discovery to control. Biomed Environ Sci, 2021; 34, 175−83.
[27] Eckels KH, Yu YX, Dubois DR, et al. Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine, 1988; 6, 513−8. doi:  10.1016/0264-410X(88)90103-X
[28] Gu PW, Ding ZE. Inactivated Japanese encephalitis (JE) vaccine made from hamster kidney cell culture (a review). Jpn Encephalitis Haemorrhagic Fever Renal Syndr Bull, 1987; 2, 15−26.
[29] Lin XJ, Liu GF, Zhang L, et al. Epidemiological analysis of the Japanese encephalitis in Shandong province during 1986-2010. Mod Prev Med, 2013; 40, 2389−91. (In Chinese
[30] Deng X, Yan R, Tang XW, et al. An analysis on epidemiological characteristics of Japanese encephalitis in Zhejiang Province. Prev Med, 2017; 29, 994−8. (In Chinese
[31] Liang J, Liu MZ, Hu P, et al. Epidemiological and clinical characteristics of Japanese encephalitis in Guangdong, 2009-2015. Mod Prev Med, 2016; 43, 3865−8. (In Chinese
[32] Shi TS, Meng L, Li DH, et al. Effect of different vaccine strategies for the control of Japanese encephalitis in mainland China from 1961 to 2020: a quantitative analysis. Vaccine, 2022; 40, 6243−54. doi:  10.1016/j.vaccine.2022.09.030
[33] Gao XY, Li XL, Li MH, et al. Vaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951-2011. PLoS Negl Trop Dis, 2014; 8, e3015. doi:  10.1371/journal.pntd.0003015
[34] Li XL, Cui SH, Gao XY, et al. The Spatio-temporal distribution of Japanese encephalitis cases in different age groups in mainland China, 2004 - 2014. PLoS Negl Trop Dis, 2016; 10, e0004611. doi:  10.1371/journal.pntd.0004611
[35] Wu D, Chen XJ, Liu WJ, et al. Emergence of Japanese encephalitis among adults 40 years of age or older in northern China: Epidemiological and clinical characteristics. Transbound Emerg Dis, 2021; 68, 3415−23. doi:  10.1111/tbed.13945
[36] Wang LH, Fu SH, Wang HY, et al. Japanese encephalitis outbreak, Yuncheng, China, 2006. Emerg Infect Dis, 2007; 13, 1123−5. doi:  10.3201/eid1307.070010
[37] Liu WJ, Fu SH, Ma XM, et al. An outbreak of Japanese encephalitis caused by genotype Ib Japanese encephalitis virus in China, 2018: A laboratory and field investigation. PLoS Negl Trop Dis, 2020; 14, e0008312. doi:  10.1371/journal.pntd.0008312
[38] Zhang XS, Jin N, Tu AX, et al. Adults in northwest China experienced the largest outbreak of Japanese encephalitis in history 10 years after the Japanese encephalitis vaccine was included in the national immunization program: A retrospective epidemiological study. J Med Virol, 2023; 95, e28782. doi:  10.1002/jmv.28782
[39] Zhang XH, Dong MX, Yang XJ, et al. Investigation on the neutralizing antibody against Japanese encephalitis virus in healthy people in Southeast Gansu province in 2018. Chin J Exp Clin Virul, 2022; 36, 591−4. (In Chinese
[40] Wang GW, Li HN, Yang XJ, et al. Guillain-barré syndrome associated with JEV infection. N Engl J Med, 2020; 383, 1188−90. doi:  10.1056/NEJMc1916977
[41] Gao XY, Liu H, Li XL, et al. Changing geographic distribution of Japanese encephalitis virus Genotypes, 1935-2017. Vector Borne Zoonotic Dis, 2019; 19, 35−44. doi:  10.1089/vbz.2018.2291
[42] Li F, Feng Y, Wang GW, et al. Tracing the spatiotemporal phylodynamics of Japanese encephalitis virus genotype I throughout Asia and the western Pacific. PLoS Negl Trop Dis, 2023; 17, e0011192. doi:  10.1371/journal.pntd.0011192
[43] Chai CX, Wang Q, Cao SJ, et al. Serological and molecular epidemiology of Japanese encephalitis virus infections in swine herds in China, 2006-2012. J Vet Sci, 2018; 19, 151−5. doi:  10.4142/jvs.2018.19.1.151
[44] Chen C, Zhao T, Jiang YT, et al. Vector mosquito ecology and Japanese encephalitis virus genotype iii strain detection from Culex tritaeniorhynchus and Pig in Huaihua, China. Vector Borne Zoonotic Dis, 2019; 19, 933−44. doi:  10.1089/vbz.2019.2453
[45] Wang LH, Fu SH, Zhang HL, et al. Identification and isolation of Genotype-I Japanese encephalitis virus from encephalitis patients. Virol J, 2010; 7, 345. doi:  10.1186/1743-422X-7-345
[46] Zhang JS, Zhao QM, Guo XF, et al. Isolation and genetic characteristics of human genotype 1 Japanese encephalitis virus, China, 2009. PLoS One, 2011; 6, e16418. doi:  10.1371/journal.pone.0016418
[47] Burke DS, Nisalak A, Ussery MA, et al. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis, 1985; 151, 1093−9. doi:  10.1093/infdis/151.6.1093